Clinical trial
Safety and Immunogenicity of CJ-50300
NCT00336635 · Seoul National University Hospital, Other · Completed
Key facts
| NCT number | NCT00336635 |
|---|---|
| Title | Safety and Immunogenicity of CJ-50300 |
| Official title | Randomized, Double Blind, Placebo Control Study to Evaluate the Safety and Immunogenicity of CJ-50300 in Healthy Volunteers : Phase I |
| Lead sponsor | Seoul National University Hospital, Other |
| Collaborators | HK inno.N Corporation Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Smallpox |
| Intervention type | Biological |
| Interventions | cell-culture derived smallpox vaccine |
| Enrollment | 24 |
| Start date | Jun 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Jun 14, 2006 |
| Last update posted | Apr 19, 2007 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: